openPR Logo
Press release

Kidney Fibrosis Treatment Market: Future market projections for forthcoming years

01-02-2018 12:48 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Kidney Fibrosis Treatment Market: Future market projections

Fibrosis is a process, which includes the formation of excess fibrous connective tissue in body tissues or organs in a repetitive manner. Kidney fibrosis is the major biological process causal for the progression of chronic kidney disease (CKD) to end-stage renal disease (ESRD). Kidney fibrosis is an unavoidable outcome of excessive formation of extracellular matrix, which occurs due to every type of CKD. Currently, the kidney fibrosis treatment market is a highly attractive commercial segment owing to the increasing base of patients suffering from various types CKD and renal fibrosis.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/kidney-fibrosis-treatment.html

It has been observed that any disease, which leads to chronic kidney disorder, might result in renal fibrosis. In terms of geography, North America is the largest market for kidney fibrosis treatment due to the large base of patients suffering from chronic kidney disease (CKD). According to the Centers for Disease Control and Prevention (CDC), in 2014, more than 20 million people in the U.S., are suffering from chronic kidney disease of varying severity levels. The organization also states that, in 2011, approximately 113,136 people in the U.S. started taking treatment for end-stage renal disease (ESRD).

Thus, this increasing base of kidney disease patients is expected to boosts the sales of kidney fibrosis treatment products. However, other regions such as South East Asia, Middle East and Latin America are some of the potential market where introduction of effective novel therapies might boosts up the overall market growth of kidney fibrosis treatment. Due to the consistent gradient of health concerns and rising awareness among population, these regions are expected to be the lucrative market venture for kidney fibrosis treatment.

Request for Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3009

Some of the major factors driving the growth of this market are increasing base of population suffering from chronic kidney diseases and high incidence rate of renal fibrosis among population. Moreover, development of safe and effective therapeutics for the treatment of kidney fibrosis is contributing to the growth of this market. For instance, in March 2014, a California based biopharmaceutical company, La Jolla Pharmaceutical Company, relieved positive results from phase II clinical trial of their proprietary GSC-100 drug molecule in chronic kidney disease (CKD). GSC-100 is a complex polysaccharide with a high molecular weight that inhibits the production of galectin-3, a molecule responsible for scarring or tissue fibrosis. Thus, the introduction of promising drugs in this market is likely to boosts the overall kidney fibrosis treatment market due to the high success and effectiveness rate of these potential molecules. Furthermore, increasing government support for developing novel therapies along with high research and development initiatives on the development of personalized medicines are also expected to fuel the growth of this market.

In addition, technological breakthrough such as point-of-care drug delivery systems and increased focus on retaining superior quality of life are some of the factors that might contribute in the growth of this market. However, rise in overall healthcare expenditure and stringent regulatory approvals are some of the market-restraining factors that might hinder the growth of the kidney fibrosis treatment market in future. At present, the kidney fibrosis treatment market is a highly lucrative and promising market due to the increasing base of population suffering from chronic kidney diseases and renal fibrosis. Various pharmaceutical and biotechnology are trying to develop novel therapeutics, which can be used for the treatment of this disorder. Some of the companies involved with the development and commercialization of therapeutic products for the treatment of kidney fibrosis are F. Hoffmann-La Roche Ltd., Galectin Therapeutics, Inc., InterMune, Inc., La Jolla Pharmaceutical Company, Merck & Co. and Pfizer, Inc., amongst others.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=3009<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kidney Fibrosis Treatment Market: Future market projections for forthcoming years here

News-ID: 881741 • Views: 99

More Releases from Transparency Market Research

Osteoporosis Drugs Market Companies Analysis, Advancement and Precise Outlook …
Transparency Market Research (TMR) has published a new report titled, ‘Osteoporosis Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Osteoporosis Drugs market was valued at US$ 11.5 Bn in 2018 and is projected to contract at a CAGR of 0.3% from 2019 to 2027. Overview Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to
Remote Patient Monitoring Devices Market News Research Report 2020
The global remote patient monitoring devices market is foreseen in a report by Transparency Market Research (TMR) to show a decently consolidated nature coupled with intense competition between key players. Recently, a larger aggregate share was held by a few prominent names of the market. F. Hoffmann-La Roche Ltd., AMD Global Telemedicine, and Honeywell HomMed LLC are some of the leading companies operating in the market. Merger and acquisition could
Oxygen Therapy Devices Market is Thriving Worldwide By Size, Revenue, Emerging T …
The demand within the global oxygen therapy devices market is projected to increase as improved medical procedures make their way into the healthcare industry. Towards the end of last year, a group of high-school students became victims of gas poisoning across a large building in Suwon. The absence of proper medical equipment for oxygen therapy became a matter of regional outrage. In this review, Transparency Market Research (TMR) looks into
Covid-19 Impact on Organic Turmeric Market: Present Scenario and Future Growth P …
The report details an exhaustive account of the global organic turmeric market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2026. From an overall perspective, the report is expected to exist as a valuable insight

All 5 Releases


More Releases for Kidney

Global Kidney Detox Market Research Report
This report studies the global Kidney Detox market status and forecast, categorizes the global Kidney Detox market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Monster Nutrition(US) Nutrionn(US) Nusapure(US) Thrive Naturals(US) Lally Naturals(US) NOW Foods(US) ReNew Life Formulas, Inc.(USA) Nutracraft(US) American Botanical
Kidney Care Specialists Launch Regional Information Website
Redesigned Kidney Care of Michiana Website Provides Access to Multiple Trusted Resources on Kidney Disease, Dialysis, and Hypertension with Dietary Guidelines Mishawaka, IN; November 1, 2018 – Kidney Care of Michiana has announced the launch of a completely redesigned website with expanded content and providing authoritative information on kidney disease, dialysis and hypertension along with appropriate dietary guidelines via some 40 links available from the new website
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA Major scientific sessions: Kidney Fluid, Electrolytes, Acid-Base Disorders Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders Chronic Kidney Disease (CKD) Kidney and Bladder stones Dialysis and Renal Care Urology/Urinary Tract Infections Kidney Transplantation Geriatric-Genetic Kidney
Kidney Cancer Drugs Market Growth Analysis 2020
A report by Transparency Market Research predicts the global market for kidney cancer drugs to expand at a 6.6% CAGR during the period between 2014 and 2020.   The global kidney cancer drugs market is dominated by a few global giants, namely F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, GlaxoSmithKline plc, and Pfizer, Inc. This makes the competitive landscape highly consolidated in nature. Competition among the players is stiff
Global Kidney Dialysis Equipment Market
The Global Kidney Dialysis Equipment Market was valued at US$ 13,930.3 million in 2015 and is projected to expand at a CAGR of 6.6% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Increasing number of End Stage Renal Disease (ESRD) patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), rapid growth in the aging population are expected to be major factors driving growth of